Evaluation of SARS-CoV-2 Sample Acquisition Efficiency and PPE Usage With and Without the Hexapod Personal Protective Booth
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28,948
- 试验地点
- 1
- 主要终点
- Change in Cost per Test After Hexapod Implementation
研究概览
简要总结
This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.
详细描述
Beginning in March 2020, the MGH began outpatient testing for COVID-19 (SARS-CoV-2) utilizing a provider-administered nasal swab samples. This was administered with infection control protocols utilizing full PPE protection for health providers who would don and doff gowns and gloves with each sample acquisition. With an aim to decrease PPE usage and increase efficiency, personal protective booths with HEPA-filtered air called "Hexapods" were employed, after infection control approval, within the MGH system beginning on April 16, 2020.
Ambulatory Care Management at MGH systematically monitors testing completed and PPE usage on a weekly basis. Managers in charge of personnel changes shared necessary team structures and median salaries for different personnel involved with sample acquisition. MGH Materials management were able to report on costs related to consumable supplies used during testing.
In this investigation, this routinely collected data and averaged timed sample collection observations were used to compare before and after the Hexapod utilization.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All testing performed at designated outpatient SARS-CoV-2 at Massachusetts General Hospital (MGH) testing sites beginning March 2019.
排除标准
- •SARS-CoV-2 tests performed not performed within designated outpatient testing sites at MGH.
- •Testing performed within the hospital for Emergency Department or Inpatient visits.
结局指标
主要结局
Change in Cost per Test After Hexapod Implementation
时间窗: Up to 22 weeks
The difference in costs of collecting test samples before and after hexapod utilization will be calculated.
Change in Testing Throughput After Hexapod Implementation
时间窗: Up to 22 weeks
Samples acquired per hour using the Hexapod booth will be assessed as an average over a minimum of 12 weeks of testing compared to baseline throughput before April 16th.
Change in Isolation Gowns Utilized After Hexapod Utilization
时间窗: Up to 22 weeks
Gowns utilized per test will be assessed as an average over a minimum of 12 weeks of testing compared to baseline throughput before April 16th.
Return on Investment
时间窗: Up to 22 weeks
The retail cost of the Hexapod booth will be divided by the average daily cost differential for testing observed and at maximum volume.
次要结局
- Change in Testing Personnel Cost Per Test(Up to 22 weeks)
- Change in Cost of Isolation Gowns Utilized(Up to 22 weeks)
研究者
Kristian R. Olson, M.D.
Director, MGH Springboard Studio
Massachusetts General Hospital